BioCentury
ARTICLE | Financial News

Knight Therapeutics proposes private placement of warrants

March 24, 2014 7:00 AM UTC

Knight President and CEO Jonathan Goodman agreed to purchase 7.6 million warrants, or about C$40 million ($36.1 million) in the offering. Knight is owned by the former Paladin Labs Inc. shareholders ...